Common Stock Alternative Reporting
OTC Pink Current Information
Contact Info
  • 303 Wyman Street
  • Suite 300
  • Waltham, MA 02451

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status Alternative Reporting Standard
Deregistered a/o May 05, 2016
Audited Financials Audited
Latest Report Dec 31, 2015 10-K
CIK 0001407038
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2835 - Diagnostic substances
Incorporated In: DE, USA
Year of Inc. 2000
Employees 5 a/o Jun 30, 2015
Company Officers/Contacts
Paul Sohmer President
Stephen Hall CFO, EVP
Aram Adourian Chief Scientific Officer
Company Directors
Noubar Afeyan
James F. O'Connor
Stelios Papadopoulos
Paul Sohmer
Harry Wilcox
Service Providers
Accounting/Auditing Firm
Deloitte & Touche
200 Berkley St.
Boston, MA, 02116
United States

Legal Counsel
Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, P.C.
One Financial Center
Boston, MA, 02111
United States

Investor Relations Firm
Not Available
BGMD Security Details
Share Structure
Market Value1 $1,528,129 a/o Oct 21, 2016
Authorized Shares 100,000,000 a/o Sep 01, 2015
Outstanding Shares 11,319,475 a/o Mar 15, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 9,394,980 a/o Sep 15, 2015
Par Value Not Available
Shareholders of Record Not Available
Short Selling Data
Short Interest 117 (0%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security